$3.71
0.02[0.54%]
Last update: 3:32PM Get Real Time Here
Atea Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Atea Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/10/2024 | PM | AVIR | Q1 | -$0.43 | -$0.61 | — | — | $0.00 | — | — | — | Get Alert |
02/28/2024 | PM | AVIR | Q4 | -$0.41 | -$0.50 | -$0.47 | 6.00% | $0.00 | — | $0.00 | — | Get Alert |
11/08/2023 | PM | AVIR | Q3 | -$0.10 | -$0.48 | -$0.40 | 16.67% | $0.00 | — | $0.00 | — | Get Alert |
08/08/2023 | PM | AVIR | Q2 | -$0.38 | -$0.47 | -$0.34 | 27.66% | $0.00 | — | $0.00 | — | Get Alert |
05/08/2023 | PM | AVIR | Q1 | -$0.51 | -$0.48 | -$0.43 | 10.42% | $0.00 | — | $0.00 | — | Get Alert |
02/28/2023 | PM | AVIR | Q4 | $1.34 | -$0.45 | -$0.41 | 8.89% | $192.18M | — | $0.00 | — | Get Alert |
11/07/2022 | PM | AVIR | Q3 | -$0.34 | -$0.44 | -$0.10 | 77.27% | $32.81M | — | $0.00 | — | Get Alert |
08/08/2022 | PM | AVIR | Q2 | $0.02 | -$0.52 | -$0.38 | 26.92% | $60.39M | — | $0.00 | — | Get Alert |
05/10/2022 | AM | AVIR | Q1 | $0.34 | -$0.58 | -$0.51 | 12.07% | $65.98M | $3.33M | $0.00 | -100.00% | Get Alert |
02/28/2022 | PM | AVIR | Q4 | $0.95 | $0.17 | $1.34 | 688.24% | $48.63M | $85.73M | $192.18M | 124.17% | Get Alert |
11/11/2021 | PM | AVIR | Q3 | -$1.74 | -$0.24 | -$0.34 | -41.67% | $0.00 | — | $32.81M | — | Get Alert |
08/12/2021 | PM | AVIR | Q2 | -$0.99 | — | $0.02 | — | — | $57.99M | $60.39M | 4.14% | Get Alert |
05/13/2021 | PM | AVIR | Q1 | — | $0.16 | $0.34 | 112.50% | — | $48.63M | $65.98M | 35.69% | Get Alert |
03/30/2021 | PM | AVIR | Q4 | — | $0.16 | $0.95 | 493.75% | — | $45.00M | $48.63M | 8.07% | Get Alert |
12/10/2020 | PM | AVIR | Q3 | — | — | -$1.74 | — | — | — | $0.00 | — | Get Alert |
Atea Pharmaceuticals (AVIR) is scheduled to report earnings on May 10, 2024. The last reported earnings were for reported on February 28, 2024 for Q4.
The Actual EPS was $-0.47, which beat the estimate of $-0.50.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.